# Role of the Gut Microbiome in Anti-tumor Therapy Induced Diarrhea

> **NCT05873231** · — · RECRUITING · sponsor: **Medical University of Graz** · enrollment: 150 (estimated)

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05873231
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-28
- **Primary completion:** 2030-12
- **Final completion:** 2032-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05873231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05873231, "Role of the Gut Microbiome in Anti-tumor Therapy Induced Diarrhea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05873231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
